Market Place
Sourcing Support
Pierre Luzeau on Seqens U.S. R&D Lab Investment
02 Jun 2023 //
CONTRACT PHARMA
SK Capital Partners completes acquisition of SEQENS and merges Wavelength Pharma
17 Dec 2021 //
PRESS RELEASE
SK Capital Partners to acquire SEQENS and merge Wavelength Pharma
26 Aug 2021 //
PRESS RELEASE
Wavelength Pharmaceuticals signs collaboration agreement with Tikun olam-Cannbit
16 Aug 2021 //
PRESS RELEASE
Biocatalysis: An Indispensable Tool for API Synthesis
07 Jun 2021 //
PRESS RELEASE
Israeli API maker Wavelength buys up majority stake in Indian firm making drug
19 Feb 2021 //
ENDPTS
Wavelength Pharmaceuticals Further Strengthens Its Global Supply Chain with Acquisition of Vanamali Organics
18 Feb 2021 //
PRESS RELEASE
Wavelength Further Strengthens Its Global Supply Chain Acquisition of Vanamali
17 Feb 2021 //
BUSINESSWIRE
HPAPI Complexity Prompts New Delivery Mechanisms
03 Dec 2020 //
PHARMTECH
Production Scale Up to Meet COVID-19 Demand
09 Sep 2020 //
CONTRACT PHARMA
Ensuring a Safe and Robust Supply of Pharma Materials
03 Aug 2020 //
PHARMTECH
Wavelength Pharmaceuticals Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19 Patients
20 Apr 2020 //
PRESS RELEASE
Wavelength Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19
20 Apr 2020 //
BIOSPACE
Wavelength Ups API Production for Essential Respiratory Meds
20 Apr 2020 //
CONTRACTPHARMA
Wavelength’s Cetirizine Dihydrochloride confirmed to be free of nitrosamine
19 Apr 2020 //
PRESS RELEASE
Wavelength’s Cilostazol confirmed to be free of nitrosamine impurities
18 Apr 2020 //
PRESS RELEASE
Wavelength Pharma Resolves a Major Supply Crisis for a Leading API Manufacturer
17 Apr 2020 //
PRESS RELEASE
Wavelength Resolves a Majo CASE STUDY Supply Crisis for a Leading API Mfg
17 Apr 2020 //
PRESS RELEASE
Wavelength Pharmaceuticals Resolves a Major Supply Crisis for a Leading API MFG
17 Apr 2020 //
PRESS RELEASE
Wavelength Resolves a Major CASE STUDY Supply Crisis for a API Manufacturer
04 Apr 2020 //
PRESS RELEASE
Wavelength will be exhibiting at Contract Pharma’s 2020 Conference
12 Mar 2020 //
PRESS RELEASE
Wavelength will be exhibiting at Contract Pharma’s 2020 Contracting
05 Feb 2020 //
PRESS RELEASE
Wavelength Pharmaceuticals Obtained on March 28th 2019 CEP For Fulvestrant
15 Apr 2019 //
PRESS RELEASE
Wavelength Pharmaceuticals Obtained on March 28th 2019 CEP For Fulvestrant
12 Mar 2019 //
PRESS RELEASE
Wavelength Pharmaceuticals completes cGMP drug process inspection audit of Neot
04 Feb 2019 //
PRESS RELEASE
Wavelength successfully completes USFDA audit at its Neot Hovav Mfg site
12 Jul 2018 //
PRESS RELEASE
Wavelength completes cGMP drug process inspection audit of Neot Hovav site
12 Mar 2018 //
PRESS RELEASE
Israeli Pharma Company Wavelength Appoints New CEO
30 Nov 2017 //
CALCALISTECH
Wavelength `S Names Iftach Seri as Chief Executive Officer and Tami Cohen as CFO
17 Nov 2017 //
BUSINESSWIRE
SK Capital will pay $110m for Perrigo`s drug ingredients business
15 Aug 2017 //
IN PHARMATECHNOLOGIST
Perrigo selling its ingredient business to investor for $110M
11 Aug 2017 //
FIERCE PHARMA
SK Capital To Buy Perrigo`s Active Pharma Ingredients Business
10 Aug 2017 //
NASDAQ
